Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review

Antibody levels correlate with detection ofTrypanosoma cruziDNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time

(2012) Ester C. Sabino et al.   TRANSFUSION

Humoral Immune Response against P2β from Trypanosoma cruzi in Persons with Chronic Chagas Disease: Its Relationship with Treatment Against Parasites and Myocardial Damage

(2011) Diana L. Fabbro et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Gastro‐intestinal Chagas disease in migrants to Spain: prevalence and methods for early diagnosis

(2011) A Pérez‐Ayala et al.   ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY

Short-term follow-up of chagasic patients after benznidazole treatment using multiple serological markers

(2011) Ana Fernández-Villegas et al.   BMC INFECTIOUS DISEASES

The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice

(2011) Andréa P de Souza et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Determinación de la concentración plasmática de proteína C reactiva en pacientes con diferentes formas clínicas de la enfermedad de Chagas

(2011) Conceição Aparecida da Silva et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Función endotelial y concentración de proteína C reactiva de alta sensibilidad en pacientes con enfermedad de Chagas que viven en áreas no endémicas

(2011) Ana García-Álvarez et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Hypercoagulability biomarkers in Trypanosoma cruzi-infected patients

(2011) Dolors Tassies et al.   THROMBOSIS AND HAEMOSTASIS

Impact of Aetiological Treatment on Conventional and Multiplex Serology in Chronic Chagas Disease

(2011) Rodolfo Viotti et al.   PLoS Neglected Tropical Diseases

International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients

(2011) Alejandro G. Schijman et al.   PLoS Neglected Tropical Diseases

Plasma  -Type Natriuretic Peptide As a Predictor of Mortality in Community-Dwelling Older Adults With Chagas Disease: 10-Year Follow-up of the Bambui Cohort Study of Aging

(2010) M. F. Lima-Costa et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Estudo de fatores pró-trombóticos e pró-inflamatórios na cardiomiopatia chagásica

(2010) Leila Maria Magalhães Pessoa de Melo et al.   Arquivos Brasileiros de Cardiologia

Stroke in Asymptomatic Trypanosoma cruzi-Infected Patients

(2010) Francisco Javier Carod-Artal et al.   CEREBROVASCULAR DISEASES

Inflammatory and Prothrombotic Activation With Conserved Endothelial Function in Patients With Chronic, Asymptomatic Chagas Disease

(2010) Ramón N. Herrera et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Chronic Chagas’ heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine

(2010) Silvia Gilka Muñoz-Saravia et al.   HEART FAILURE REVIEWS

Increased levels of IgA antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi differentiate digestive forms of Chagas disease

(2010) Romero H.T. Vasconcelos et al.   HUMAN IMMUNOLOGY

Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country

(2010) L. Murcia et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Amino-terminal Fragment of C-type Natriuretic Peptide Precursor and C-type Natriuretic Peptide Do Not Correlate in Patients With Chagas Disease: Role For Neutral Endopeptidase

(2010) Yong Wang et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Identification of Novel Diagnostic Serum Biomarkers for Chagas' Disease in Asymptomatic Subjects by Mass Spectrometric Profiling

(2010) M. Ndao et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Distinct Patterns of Autoantibodies Against G-Protein–Coupled Receptors in Chagas' Cardiomyopathy and Megacolon

(2010) Silvia Gilka Muñoz Saravia et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Distinct Patterns of Autoantibodies Against G-Protein–Coupled Receptors in Chagas' Cardiomyopathy and Megacolon

(2010) Gerd Wallukat et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Chagas disease

(2010) Anis Rassi et al.   LANCET

Chagas disease and stroke

(2010) Francisco Javier Carod-Artal et al.   LANCET NEUROLOGY

The role of selenium in intestinal motility and morphology in a murine model of Typanosoma cruzi infection

(2010) Andréa Pereira de Souza et al.   PARASITOLOGY RESEARCH

Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage

(2010) Ana Garcia-Alvarez et al.   PLoS Neglected Tropical Diseases

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

(2009) et al.   CIRCULATION

Increased Myeloperoxidase Activity and Protein Nitration Are Indicators of Inflammation in Patients with Chagas' Disease

(2009) M. Dhiman et al.   Clinical and Vaccine Immunology

Changes inTrypanosoma cruzi–Specific Immune Responses after Treatment: Surrogate Markers of Treatment Efficacy

(2009) Susana A. Laucella et al.   CLINICAL INFECTIOUS DISEASES

Plasma concentrations of tumour necrosis factor-alpha, tumour necrosis factor-related apoptosis-inducing ligand, and FasLigand/CD95L in patients with Chagas cardiomyopathy correlate with left ventricular dysfunction

(2009) Jamille Fernandes Lula et al.   EUROPEAN JOURNAL OF HEART FAILURE

Plasma ACE2 Activity is an Independent Prognostic Marker in Chagas' Disease and Equally Potent as BNP

(2009) Yong Wang et al.   JOURNAL OF CARDIAC FAILURE

Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy

(2009) Edecio Cunha-Neto et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations

(2009) Constança Carvalho Britto   MEMORIAS DO INSTITUTO OSWALDO CRUZ

The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives

(2009) Antoniana Ursine Krettli   MEMORIAS DO INSTITUTO OSWALDO CRUZ

The role of parasite persistence in pathogenesis of Chagas heart disease

(2009) F. R. S. GUTIERREZ et al.   PARASITE IMMUNOLOGY

Chagas Disease

(2009) Leonardo C. Paixão et al.   STROKE

The anti-oxidant defence response in individuals with the indeterminate form of Chagas disease (American trypanosomiasis)

(2008) R. Pérez-Fuentes et al.   ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY

Níveis séricos de NT pro-BNP: relação com função sistólica e diastólica nas miocardiopatias e pericardiopatias

(2008) Charles Mady et al.   Arquivos Brasileiros de Cardiologia

Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure

(2008) Slava Epelman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease

(2008) Juan M Bustamante et al.   NATURE MEDICINE

Trypanosoma cruziInfection of Cultured Adipocytes Results in an Inflammatory Phenotype

(2008) Fnu Nagajyothi et al.   Obesity

Strategy to Assess the Overall Cytokine Profile of Circulating Leukocytes and its Association with Distinct Clinical Forms of Human Chagas Disease

(2008) D. M. Vitelli-Avelar et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Microparticles in vascular diseases

(2008) Françoise Dignat George   THROMBOSIS RESEARCH

High Throughput Selection of Effective Serodiagnostics for Trypanosoma cruzi infection

(2008) Gretchen Cooley et al.   PLoS Neglected Tropical Diseases